Evidence map›Paper›PMID 26455498›Full record

Trial reportJournal of genetic counseling2016

Patient Perceptions of Telephone vs. In-Person BRCA1/BRCA2 Genetic Counseling.

Beth N Peshkin, Scott Kelly, Rachel H Nusbaum, Morgan Similuk, Tiffani A DeMarco, Gillian W Hooker, Heiddis B Valdimarsdottir, Andrea D Forman, Jessica Rispoli Joines, Claire Davis and 8 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of genetic counseling, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Virtual Care in Patients with Cancer: A Systematic Review.Current oncology (Toronto, Ont.) · 2021
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Review
  11. Article
  12. Review
  13. Implementation of a National Prenatal Exome Sequencing Service in England: Cost-Effectiveness Analysis.BJOG : an international journal of obstetrics and gynaecology · 2025
    Article
  14. Article
  15. Transforming patient-centered cancer care using telehealth: the MATCHES Center.Journal of the National Cancer Institute. Monographs · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 14 institutions in 2 countries.

Beth N PeshkinDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. peshkinb@georgetown.edu.
Scott KellyDepartment of Epidemiology and Biostatistics, George Washington University, Washington, DC, USA.
Rachel H NusbaumGeneDx, Gaithersburg, MD, USA.
Morgan SimilukNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Tiffani A DeMarcoCancer Genetic Counseling Program, Inova Translational Medicine Institute, Inova Health System, Falls Church, VA, USA.
Gillian W HookerNextGxDx, Inc, Franklin, TN, USA.
Heiddis B ValdimarsdottirDepartment of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Andrea D FormanDepartment of Clinical Genetics, Risk Assessment Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
Jessica Rispoli JoinesDepartment of Medicine, Division of Hematology/Oncology, Marlene and Stewart Greenebaum Cancer Center, University of Maryland Medical Center, Baltimore, MD, USA.
Claire DavisJoan H. Marks Graduate Program in Human Genetics, Sarah Lawrence College, Yonkers, NY, USA.
Shelley R McCormickCenter for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Wendy McKinnonFamilial Cancer Program, University of Vermont Cancer Center, Burlington, VT, USA.
Kristi D GravesDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Claudine IsaacsDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Judy GarberCenter for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Marie WoodFamilial Cancer Program, University of Vermont Cancer Center, Burlington, VT, USA.
Lina JandorfDepartment of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Marc D SchwartzDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Hereditary Disease Foundation · USIcahn School of Medicine at Mount Sinai · USVermont Cancer Support Network · USCancer Genetics (United States) · USDana-Farber Cancer Institute · USFox Chase Cancer Center · USGeorgetown University · USGeorgetown University Medical Center · USGeorge Washington University · USGTx (United States) · USInova Health System · USNational Institutes of Health · USSarah Lawrence College · USUniversity of Maryland, Baltimore · US

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI Louis M Weiner · 1990 to 2026
$71.5M
Telephone-Based Genetic Counseling: An Equivalence TrialR01CA108933 · NCI · GEORGETOWN UNIVERSITY · PI SCHWARTZ, MARC D · 2004 to 2008
$2.3M
NCI NIH HHS P30 CA051008NCI NIH HHS R01 CA108933
6 · The paper itself

Abstract

Telephone genetic counseling (TC) for hereditary breast/ovarian cancer risk has been associated with positive outcomes in high risk women. However, little is known about how patients perceive TC. As part of a randomized trial of TC versus usual care (UC; in-person genetic counseling), we compared high risk women's perceptions of: (1) overall satisfaction with genetic counseling; (2) convenience; (3) attentiveness during the session; (4) counselor effectiveness in providing support; and (5) counselor ability to recognize emotional responses during the session. Among the 554 participants (TC, N = 272; UC, N = 282), delivery mode was not associated with self-reported satisfaction. However, TC participants found counseling significantly more convenient than UC participants (OR = 4.78, 95 % CI = 3.32, 6.89) while also perceiving lower levels of support (OR = 0.56, 95 % CI = 0.40-0.80) and emotional recognition (OR = 0.53, 95 % CI = 0.37-0.76). In exploratory analyses, we found that non-Hispanic white participants reported higher counselor support in UC than in TC (69.4 % vs. 52.8 %; OR = 3.06, 95 % CI = 1.39-6.74), while minority women perceived less support in UC vs. TC (58.3 % vs. 38.7 %; OR = 0.80, 95 % CI = 0.39-1.65). We discuss potential research and practice implications of these findings which may further improve the effectiveness and utilization of TC.

Indexed as

Genes, BRCA1Genes, BRCA2Genetic Predisposition to DiseaseTelephoneAdultBreast NeoplasmsFemaleGenetic CounselingGenetic TestingHumansMiddle AgedPatient SatisfactionProgram EvaluationSelf ReportBRCA1/BRCA2Genetic counselingPatient satisfactionTelephone counseling

Identifiers

PMID26455498
PMCPMC4829475
OpenAlexW1898642804

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.